MedPath

Brief group interventions with breast cancer survivors

Completed
Conditions
Breast cancer survivors
Cancer
Malignant neoplasm of breast
Registration Number
ISRCTN75243042
Lead Sponsor
Portuguese Foundation of Science and Technology (Fundação ciência e tecnologia) (FCT) (Portugal)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
62
Inclusion Criteria

1. Over 18 years old
2. Received breast cancer diagnosis and treatment
3. Does not present currently signals of disease

Exclusion Criteria

1. Younger than 18 years old
2. Inability to participate in groups
3. Conflicts with other members of group
4. History of other psychiatric disorders prior to illness
5. Suicidal ideation
6. Dependence on psychoactive substances (such drugs and alcohol)
7. Organic brain disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acceptability and feasibility will be measured: <br>1. Participant uptake of the intervention <br>2. Intervention session attendance <br>3. Rates of participant drop-out<br><br>Measured at pre-test, baseline, post-test: final intervention, 3 months follow-up and 6 months follow-up
Secondary Outcome Measures
NameTimeMethod
1. Cancer Coping Questionnaire (CCQ)<br>2. Courtauld Emotional Control Scale (CEC)<br>3. Hospital Anxiety and Depression Scale (HADS)<br>4. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire with the Supplementary Questionnaire Breast Cancer Module (EORTC QLQ - C30 and BR -23)<br>5. Self-Concept Clinical Inventory (ICAC)<br>6. Life Orientation Test - Revised (LOT-R)<br>7. Patient Health Questionnaire (PHQ-9)<br>8. Profile of Mood States (POMS)<br>9. Personal Growth subscale of the Scale of Psychological Well-Being (EBEP)<br>10. Sub-scale of Spirituality <br>11. Inventory of State - Trait anxiety (STAI)<br><br>Measured at baseline, after 8 weeks, 3 months and 6 months
© Copyright 2025. All Rights Reserved by MedPath